Abstract
The cost of psychiatric care reflects the psychiatric, psychological and psychotherapeutic care provided by all segments of the system, i.e. outpatient, acute inpatient and follow-up inpatient care. Health insurance companies pay for outpatient care and psychopharmacology treatment prescribed by prescription.
The costs of mental health are not the final cost to insurance companies, that go into psychiatric care. At present there is no record of the amount consumed services, especially psychotherapy, that are paid directly by patients.
Other direct costs to patients go towards the purchase of over-the-counter products that are used to alleviate various types of mental health problems. Total costs spent by health insurance companies on psychiatric for psychiatric care in 2020 was approximately 16 billion CZK, with the largest share of financial of the funds goes to providers of follow-up care (CZK 7 billion).
For medicinal products, health insurance companies paid approximately CZK 3 billion. In the framework of the gradual changes related to the psychiatric reform of the reform of psychiatric care, there will be changes the proportion of funds spent on individual areas.
Currently, it can be stated that, there is an increase in all segments, but in no case is there shifting of funding to the detriment of any other area. Highest increase has been recorded in the outpatient segment psychiatric care, with the largest increase in the outpatient sector compared to the previous year 2017 increased by 44%.